These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 10520719)

  • 1. A novel potential application for 99mTc-HMPAO: endothelial cell labeling for in vitro investigation of cell-biomaterial interactions.
    Fernandez P; Bordenave L; Celerier C; Bareille R; Brouillaud B; Basse-Cathalinat B
    J Nucl Med; 1999 Oct; 40(10):1756-63. PubMed ID: 10520719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on flow-independent mechanisms of 99mTc-HMPAO retention in nervous tissue: in vitro study.
    Colamussi P; Calò G; Sbrenna S; Uccelli L; Bianchi C; Cittanti C; Siniscalchi A; Giganti M; Roveri R; Piffanelli A
    J Nucl Med; 1999 Sep; 40(9):1556-62. PubMed ID: 10492379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparison of equine granulocytes labeled with 99mTc-hexamethylpropyleneamine oxime or 111In-oxine.
    Daniel GB; Tucker RL; Buckman T; Daniel SL
    Am J Vet Res; 1992 Jun; 53(6):871-6. PubMed ID: 1626776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro assessment of cytotoxicity and labeling efficiency of 99mTc-HMPAO with stromal vascular fraction of adipose tissue.
    Verma VK; Beevi SS; Tabassum A; Kumaresan K; Kamaraju RS; Arbab AS; Chelluri LK
    Nucl Med Biol; 2014 Oct; 41(9):744-8. PubMed ID: 25037755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-HMPAO as a tracer of cerebral blood flow in newborn infants.
    Børch K; Greisen G
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):448-54. PubMed ID: 9143227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content.
    Blocklet D; Toungouz M; Kiss R; Lambermont M; Velu T; Duriau D; Goldman M; Goldman S
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):440-7. PubMed ID: 12722741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of stabilized 99mTc-D,L-HMPAO stored in vials and syringes.
    Del Carmen Plancha-Mansanet M; Caballero-Calabuig E; Félix-Fontestad J; Reyes-Ojeda MD; Sopena-Novales P; Abreu-Sánchez P; Del Carmen Cano-Terol M; Sopena-Monforte R
    J Nucl Med Technol; 2008 Dec; 36(4):213-6. PubMed ID: 19008289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
    Andersen AR
    Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of glutathione localization in brain using 99mTc meso-HMPAO.
    Sasaki T; Senda M
    J Nucl Med; 1999 Jun; 40(6):1056-60. PubMed ID: 10452324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an in vitro endothelialized vascular graft under pulsatile shear stress with a novel radiolabeling procedure.
    Fernandez P; Bareille R; Conrad V; Midy D; Bordenave L
    Biomaterials; 2001 Apr; 22(7):649-58. PubMed ID: 11246958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-HMPAO labelling inhibits cell motility and cell proliferation and induces apoptosis of NC-NC cells.
    Ulker O; Genç S; Ateş H; Durak H; Atabey N
    Mutat Res; 2007 Jul; 631(2):69-76. PubMed ID: 17512775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of stabilized technetium-99m-exametazime for radiolabeling leukocytes.
    Hung JC; Chowdhury S; Mullan BP
    J Nucl Med; 1998 May; 39(5):912-7. PubMed ID: 9591600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of decreased chemotaxis of technetium-99m-HMPAO-labeled lymphocytes to apoptosis.
    Van de Wiele C; Philippé J; Van Haelst JP; Van Damme J; Thierens H; Leroux-Roels GE; Dierckx RA
    J Nucl Med; 1997 Sep; 38(9):1417-21. PubMed ID: 9293800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution and radiation dosimetry of stabilized 99mTc-exametazine-labeled leukocytes in normal subjects.
    Robins PD; Salazar I; Forstrom LA; Mullan BP; Hung JC
    J Nucl Med; 2000 May; 41(5):934-40. PubMed ID: 10809211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methylene blue stabilizer on in vitro viability and chemotaxis of 99mTc-exametazime-labeled leukocytes.
    Hung JC; Iverson BC; Toulouse KA; Mahoney DW
    J Nucl Med; 2002 Jul; 43(7):928-32. PubMed ID: 12097465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional upregulation of granulocytes labeled with technetium-99m-HMPAO and indium-111-oxinate.
    Bertrand-Caix J; Freyburger G; Bordenave L; Labrouche S; Bareille R; Baquey C; Ducassou D; Lefebvre F
    J Nucl Med; 1996 May; 37(5):863-8. PubMed ID: 8965165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
    García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
    Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine application of fractionated HMPAO stored at -70 degrees C for WBC scintigraphy.
    Morrissey GJ; Powe JE
    J Nucl Med; 1993 Jan; 34(1):151-5. PubMed ID: 8418259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental detection of multiple abdominopelvic splenosis sites during Tc-99m HMPAO-labeled leukocyte scintigraphy.
    Turkmen C; Yormaz E
    Clin Nucl Med; 2006 Sep; 31(9):572-4. PubMed ID: 16921290
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte labeling with technetium-99m-HMPAO: a radiotoxicity study using the micronucleus assay.
    Thierens HM; Vral AM; Van Haelst JP; Van de Wiele C; Schelstraete KH; de Ridder LI
    J Nucl Med; 1992 Jun; 33(6):1167-74. PubMed ID: 1597733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.